main content start
Showing Results for: “Glycemic Index and Diabetes”
Vitamin D Supplements Do Not Significantly Reduce Risk of Developing Type 2 Diabetes, According to Research Presented Today at the ADA’s Scientific Sessions
New research shows that daily oral vitamin D supplementation does not effectively reduce the risk of type 2 diabetes among vitamin D-sufficient adults at high risk for developing the disease, according to the “The Vitamin D and Type 2 Diabetes (D2d) Study – A Multicenter Randomized Controlled Trial for Diabetes Prevention” study presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco. More than 84 million Americans have prediabetes, which is a precursor of symptoms indicating higher risk of progression to type
New Formulations of GLP-1s Demonstrate Positive Results, Potentially Offering Additional Options for Obesity Medications
Data reveals potential for once-daily oral and monthly injectable treatment alternatives for patients with type 2 diabetes and obesity Findings from two breakthrough studies reveal positive outcomes for two medications - orfoglipron and MariTide (maridebart cafraglutide) – expanding the treatment of type two diabetes and obesity. Results from the ACHIEVE-1 Trial and the MariTide Phase 2 Trial were simultaneously published in the New England Journal of Medicine (NEJM) and presented as late-breaking symposia at the American Diabetes Association’s® (ADA) 85th Scientific Sessions in Chicago. As of
Common Terms
Browse list of diabetes-related terms and their definitions- Adapted from NIDDK.
Give Today and Change lives!
With your support, the American Diabetes Association® can continue our lifesaving work to make breakthroughs in research and provide people with the resources they need to fight diabetes.